Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

In patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes, myocardial infarction, or stroke. Rivaroxaban also reduced overall mortality, although there was more bleeding. After an acute coronary syndrome,...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The New England journal of medicine Ročník 366; číslo 1; s. 9 - 19
Hlavní autori:	Mega, Jessica L, Braunwald, Eugene, Wiviott, Stephen D, Bassand, Jean-Pierre, Bhatt, Deepak L, Bode, Christoph, Burton, Paul, Cohen, Marc, Cook-Bruns, Nancy, Fox, Keith A.A, Goto, Shinya, Murphy, Sabina A, Plotnikov, Alexei N, Schneider, David, Sun, Xiang, Verheugt, Freek W.A, Gibson, C. Michael
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Waltham, MA Massachusetts Medical Society 05.01.2012
Predmet:	Acute Coronary Syndrome - drug therapy Acute coronary syndromes Aged Angina pectoris Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Arteriosclerosis Biological and medical sciences Bleeding Cardiology. Vascular system Cardiovascular disease Cardiovascular Diseases - epidemiology Cardiovascular Diseases - mortality Cardiovascular Diseases - prevention & control Cerebral infarction Coronary artery Coronary heart disease Death Double-Blind Method Drug Administration Schedule Factor Xa Inhibitors Female General aspects Heart Heart attacks Heart surgery Hemorrhage Hemorrhage - chemically induced Hemorrhage - mortality Humans Incidence Intracranial Hemorrhages - chemically induced Kaplan-Meier Estimate Male Medical sciences Middle Aged Morpholines - administration & dosage Morpholines - adverse effects Morpholines - therapeutic use Myocardial infarction Myocarditis. Cardiomyopathies Rivaroxaban Secondary Prevention Thiophenes - administration & dosage Thiophenes - adverse effects Thiophenes - therapeutic use Thrombosis Human Medicine Rivaroxaban Antithrombotic agent Cardiovascular disease Patient Acute coronary syndrome Coronary heart disease Myocardial disease
ISSN:	0028-4793, 1533-4406, 1533-4406
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!